Newsletter – August 2022 – Biotech Fund
The question we wanted answered in July was “can the rally last?” August provided the answer. Read more.
READ MOREOzHarvest – Help Keep The Wheels Turning + Provide Vital Food Relief
I’m helping OzHarvest raise money to feed people in need and I’d love your support. Read more.
READ MORENewsletter – October 2021
The market seems to be trading sideways now albeit with a slight downward trend back towards the 30 Day Moving Average level on the XJO (ASX 200) of 7358 points.
READ MOREThe Insider- Meet the Fund Manager with Reach Markets
Andrew Chapman presented a session for Reach Markets series, The Insider- Meet the Fund Manager. These sessions are about getting an overview from a leading manager to of their approach, discuss the market, the trends and sectors they are interested in, and their favourite stocks. The session was recorded on the 19th November, 2021. You […]
READ MOREPodcast- Masters of the Market
In this episode Chris Judd heads to Perth to catch up with the Managing Director of the Merchant Group Andrew Chapman. With almost 20 years of experience in the industry, Andrew walks us through his experiences in investing in biotech stocks, medical marijuana and other micro caps. Published 19 June 2019. Click the image below […]
READ MOREPodcast- Talk Ya Book 2021
In this week’s episode of Chris Judd Invest Channel’s Talk Ya Book Andrew Chapman from Merchant Group will talk about an Australian medical diagnostics company and a very exciting small cap potash play. Recorded 2nd March 2021
READ MOREPodcast- Talk Ya Book 2020
On this edition of Talk Ya Book from the Chris Judd Invest Channel, Andrew Chapman from Merchant Funds Management talks through an ASX listed bio-tech that he feels has a lot of potential. $ASX $RAC- recorded 18th July 2020
READ MORENewsletter – September 2020
The Merchant Leaders Fund (MLF) has continued to perform above the ASX 100 (XTO) with the Fund up 3.70% to the end of September.
READ MORE